Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity

Nucleic Acids Research

Volumn 42, Issue 1, 2014, Pages 396-416

  Horn, Axel V ^a,b   Klawitter, Sabine ^a   Held, Ulrike ^a   Berger, André ^a   Jaguva Vasudevan, Ananda Ayyappan ^c   Bock, Anja ^a   Hofmann, Henning ^a,e   Hanschmann, Kay Martin O ^a   Trösemeier, Jan Hendrik ^a   Flory, Egbert ^a   Jabulowsky, Robert A ^a,d   Han, Jeffrey S ^b   Löwer, Johannes ^a   Löwer, Roswitha ^a   Münk, Carsten ^a,c   Schumann, Gerald G ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b GEOPHYSICAL LABORATORY   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3C; BINDING PROTEIN; CYTIDINE DEAMINASE; ORF1 PROTEIN; RIBONUCLEOPROTEIN; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; COMPLEMENTARY DNA; DEAMINASE; G3BP PROTEIN; L1 RIBONUCLEOPROTEIN; MARKER;

ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DIMERIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; LONG INTERSPERSED REPEAT; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RETROPOSON; CELL GRANULE; CYTOPLASM; ECTOPIC EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LINE 1 RETROTRANSPOSON; RNA BINDING; SUCROSE GRADIENT;

EID: 84891804319     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt898     Document Type: Article

References (105)

1. Goodier, J.L. and Kazazian, H.H. Jr (2008) Retrotransposons revisited: The restraint and rehabilitation of parasites. Cell, 135, 23-35
2. Solyom, S. and Kazazian, H.H. Jr (2012) Mobile elements in the human genome: Implications for disease. Genome Med., 4, 12
3. Kazazian, H.H. Jr, Wong, C., Youssoufian, H., Scott, A.F., Phillips, D.G. and Antonarakis, S.E. (1988) Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature, 332, 164-166
4. Hancks, D.C. and Kazazian, H.H. Jr (2012) Active human retrotransposons: Variation and disease. Curr. Opin. Genet. Dev., 22, 191-203
5. Gasior, S.L., Wakeman, T.P., Xu, B. and Deininger, P.L. (2006) The human LINE-1 retrotransposon creates DNA double-strand breaks. J. Mol. Biol., 357, 1383-1393
6. Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.G., Ohgi, K., Zhang, J., Rose, D.W., Fu, X.D., Glass, C.K. et al. (2009) Nuclear receptorinduced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell, 139, 1069-1083
7. Yu, F., Zingler, N., Schumann, G. and Stratling, W.H. (2001) Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res., 29, 4493-4501
8. Bourc'his, D. and Bestor, T.H. (2004) Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature, 431, 96-99
9. Yoder, J.A., Walsh, C.P. and Bestor, T.H. (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13, 335-340
10. Yang, N. and Kazazian, H.H. Jr (2006) L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat. Struct. Mol. Biol., 13, 763-771
11. Malone, C.D. and Hannon, G.J. (2009) Small RNAs as guardians of the genome. Cell, 136, 656-668
12. Aravin, A.A., Sachidanandam, R., Girard, A., Fejes-Toth, K. and Hannon, G.J. (2007) Developmentally regulated piRNA clusters implicate MILI in transposon control. Science, 316, 744-747
13. Suzuki, J., Yamaguchi, K., Kajikawa, M., Ichiyanagi, K., Adachi, N., Koyama, H., Takeda, S. and Okada, N. (2009) Genetic evidence that the non-homologous end-joining repair pathway is involved in LINE retrotransposition. PLoS Genet., 5, e1000461
14. Gasior, S.L., Roy-Engel, A.M. and Deininger, P.L. (2008) ERCC1/XPF limits L1 retrotransposition. DNA Repair, 7, 983-989
15. Stetson, D.B., Ko, J.S., Heidmann, T. and Medzhitov, R. (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell, 134, 587-598
16. Levin, H.L. and Moran, J.V. (2011) Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet., 12, 615-627
17. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J. and Navaratnam, N. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics, 79, 285-296
18. Conticello, S.G., Harris, R.S. and Neuberger, M.S. (2003) The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol., 13, 2009-2013
19. Conticello, S.G., Thomas, C.J., Petersen-Mahrt, S.K. and Neuberger, M.S. (2005) Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol., 22, 367-377
20. Münk, C., Willemsen, A. and Bravo, I.G. (2012) An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals. BMC Evol. Biol., 12, 71
21. Refsland, E.W., Stenglein, M.D., Shindo, K., Albin, J.S., Brown, W.L. and Harris, R.S. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: Implications for HIV-1 restriction. Nucleic Acids Res., 38, 4274-4284
22. Chiu, Y.L. and Greene, W.C. (2008) The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol., 26, 317-353
23. Schumann, G.G., Gogvadze, E.V., Osanai-Futahashi, M., Kuroki, A., Münk, C., Fujiwara, H., Ivics, Z. and Buzdin, A.A. (2010) Unique functions of repetitive transcriptomes. Int. Rev. Cell Mol. Biol., 285, 115-188
24. Beale, R.C., Petersen-Mahrt, S.K., Watt, I.N., Harris, R.S., Rada, C. and Neuberger, M.S. (2004) Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: Correlation with mutation spectra in vivo. J. Mol. Biol., 337, 585-596
25. Bishop, K.N., Holmes, R.K., Sheehy, A.M., Davidson, N.O., Cho, S.J. and Malim, M.H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol., 14, 1392-1396
26. Harris, R.S., Bishop, K.N., Sheehy, A.M., Craig, H.M., Petersen- Mahrt, S.K., Watt, I.N., Neuberger, M.S. and Malim, M.H. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell, 113, 803-809
27. Lecossier, D., Bouchonnet, F., Clavel, F. and Hance, A.J. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science, 300, 1112
28. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L. and Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature, 424, 99-103
29. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Münk, C., Nymark-McMahon, H. and Landau, N.R. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell, 114, 21-31
30. Suspene, R., Sommer, P., Henry, M., Ferris, S., Guetard, D., Pochet, S., Chester, A., Navaratnam, N., Wain-Hobson, S. and Vartanian, J.P. (2004) APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res., 32, 2421-2429
31. Vartanian, J.P., Henry, M., Marchio, A., Suspene, R., Aynaud, M.M., Guetard, D., Cervantes-Gonzalez, M., Battiston, C., Mazzaferro, V., Pineau, P. et al. (2010) Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog., 6, e1000928
32. Stenglein, M.D., Burns, M.B., Li, M., Lengyel, J. and Harris, R.S. (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol., 17, 222-229
33. Holmes, R.K., Malim, M.H. and Bishop, K.N. (2007) APOBECmediated viral restriction: Not simply editing? Trends Biochem. Sci., 32, 118-128
34. Holmes, R.K., Koning, F.A., Bishop, K.N. and Malim, M.H. (2007) APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem., 282, 2587-2595
35. Bogerd, H.P., Wiegand, H.L., Doehle, B.P., Lueders, K.K. and Cullen, B.R. (2006) APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res., 34, 89-95
36. Stenglein, M.D. and Harris, R.S. (2006) APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem., 281, 16837-16841
37. Muckenfuss, H., Hamdorf, M., Held, U., Perkovic, M., Löwer, J., Cichutek, K., Flory, E., Schumann, G.G. and Münk, C. (2006) APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem., 281, 22161-22172
38. Gilbert, N., Lutz, S., Morrish, T.A. and Moran, J.V. (2005) Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol., 25, 7780-7795
39. Bogerd, H.P., Wiegand, H.L., Hulme, A.E., Garcia-Perez, J.L., O'Shea, K.S., Moran, J.V. and Cullen, B.R. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl Acad. Sci. USA, 103, 8780-8785
40. Bogerd, H.P., Wiegand, H.L., Doehle, B.P. and Cullen, B.R. (2007) The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains. Virology, 364, 486-493
41. Pak, V., Heidecker, G., Pathak, V.K. and Derse, D. (2011) The role of amino-Terminal sequences in cellular localization and antiviral activity of APOBEC3B. J. Virol., 85, 8538-8547
42. MacDuff, D.A., Demorest, Z.L. and Harris, R.S. (2009) AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res., 37, 1854-1867
43. Chen, H., Lilley, C.E., Yu, Q., Lee, D.V., Chou, J., Narvaiza, I., Landau, N.R. and Weitzman, M.D. (2006) APOBEC3A is a potent inhibitor of adeno-Associated virus and retrotransposons. Curr. Biol., 16, 480-485
44. Narvaiza, I., Linfesty, D.C., Greener, B.N., Hakata, Y., Pintel, D.J., Logue, E., Landau, N.R. and Weitzman, M.D. (2009) Deaminaseindependent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog., 5, e1000439
45. Zielonka, J., Bravo, I.G., Marino, D., Conrad, E., Perkovic, M., Battenberg, M., Cichutek, K. and Münk, C. (2009) Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases. J. Virol., 83, 7547-7559
46. Niewiadomska, A.M., Tian, C., Tan, L., Wang, T., Sarkis, P.T. and Yu, X.F. (2007) Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-masscomplex formation or P-body association. J. Virol., 81, 9577-9583
47. Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D. and Landau, N.R. (2004) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem., 279, 53379-53386
48. Mahieux, R., Suspene, R., Delebecque, F., Henry, M., Schwartz, O., Wain-Hobson, S. and Vartanian, J.P. (2005) Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. J. Gen. Virol., 86, 2489-2494
49. Henry, M., Guetard, D., Suspene, R., Rusniok, C., Wain-Hobson, S. and Vartanian, J.P. (2009) Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One, 4, e4277
50. Langlois, M.A., Beale, R.C., Conticello, S.G. and Neuberger, M.S. (2005) Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res., 33, 1913-1923
51. Bourara, K., Liegler, T.J. and Grant, R.M. (2007) Target cell APOBEC3C can induce limited G-To-A mutation in HIV-1. PLoS. Pathog., 3, 1477-1485
52. Dutko, J.A., Schafer, A., Kenny, A.E., Cullen, B.R. and Curcio, M.J. (2005) Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr. Biol., 15, 661-666
53. Schumacher, A.J., Nissley, D.V. and Harris, R.S. (2005) APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl Acad. Sci. USA, 102, 9854-9859
54. Baumert, T.F., Rosler, C., Malim, M.H. and von Weizsacker, F. (2007) Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology, 46, 682-689
55. Kock, J. and Blum, H.E. (2008) Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J. Gen. Virol., 89, 1184-1191
56. Suspene, R., Aynaud, M.M., Guetard, D., Henry, M., Eckhoff, G., Marchio, A., Pineau, P., Dejean, A., Vartanian, J.P. and Wain- Hobson, S. (2011) Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl Acad. Sci. USA, 108, 4858-4863
57. Vartanian, J.P., Guetard, D., Henry, M. and Wain-Hobson, S. (2008) Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science, 320, 230-233
58. Suspene, R., Aynaud, M.M., Koch, S., Pasdeloup, D., Labetoulle, M., Gaertner, B., Vartanian, J.P., Meyerhans, A. and Wain-Hobson, S. (2011) Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol., 85, 7594-7602
59. Khatua, A.K., Taylor, H.E., Hildreth, J.E. and Popik, W. (2010) Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F. Virology, 400, 68-75
60. Kinomoto, M., Kanno, T., Shimura, M., Ishizaka, Y., Kojima, A., Kurata, T., Sata, T. and Tokunaga, K. (2007) All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res., 35, 2955-2964
61. Kimberland, M.L., Divoky, V., Prchal, J., Schwahn, U., Berger, W. and Kazazian, H.H. Jr (1999) Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum. Mol. Genet., 8, 1557-1560
62. Kulpa, D.A. and Moran, J.V. (2005) Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum. Mol. Genet., 14, 3237-3248
63. Stauch, B., Hofmann, H., Perkovic, M., Weisel, M., Kopietz, F., Cichutek, K., Münk, C. and Schneider, G. (2009) Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation. Proc. Natl Acad. Sci. USA, 106, 12079-12084
64. Hulme, A.E., Bogerd, H.P., Cullen, B.R. and Moran, J.V. (2007) Selective inhibition of Alu retrotransposition by APOBEC3G. Gene, 390, 199-205
65. Wei, W., Morrish, T.A., Alisch, R.S. and Moran, J.V. (2000) A transient assay reveals that cultured human cells can accommodate multiple LINE-1 retrotransposition events. Anal. Biochem., 284, 435-438
66. Ostertag, E.M., Prak, E.T., DeBerardinis, R.J., Moran, J.V. and Kazazian, H.H. Jr (2000) Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res., 28, 1418-1423
67. Wei, W., Gilbert, N., Ooi, S.L., Lawler, J.F., Ostertag, E.M., Kazazian, H.H. Jr, Boeke, J.D. and Moran, J.V. (2001) Human L1 retrotransposition: Cis preference versus trans complementation. Mol. Cell. Biol., 21, 1429-1439
68. Raiz, J., Damert, A., Chira, S., Held, U., Klawitter, S., Hamdorf, M., Löwer, J., Stratling, W.H., Löwer, R. and Schumann, G.G. (2012) The non-Autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res., 40, 1666-1683
69. Kamentsky, L., Jones, T.R., Fraser, A., Bray, M.A., Logan, D.J., Madden, K.L., Ljosa, V., Rueden, C., Eliceiri, K.W. and Carpenter, A.E. (2011) Improved structure, function and compatibility for CellProfiler: Modular high-Throughput image analysis software. Bioinformatics, 27, 1179-1180
70. Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F. and Malim, M.H. (2009) RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog., 5, e1000330
71. Kulpa, D.A. and Moran, J.V. (2006) Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat. Struct. Mol. Biol., 13, 655-660
72. Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K. and Landau, N.R. (2005) Complementary function of the two catalytic domains of APOBEC3G. Virology, 333, 374-386
73. Newman, E.N., Holmes, R.K., Craig, H.M., Klein, K.C., Lingappa, J.R., Malim, M.H. and Sheehy, A.M. (2005) Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol., 15, 166-170
74. Wissing, S., Montano, M., Garcia-Perez, J.L., Moran, J.V. and Greene, W.C. (2011) Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J. Biol. Chem., 286, 36427-36437
75. Moran, J.V., Holmes, S.E., Naas, T.P., DeBerardinis, R.J., Boeke, J.D. and Kazazian, H.H. Jr (1996) High frequency retrotransposition in cultured mammalian cells. Cell, 87, 917-927
76. Brouha, B., Schustak, J., Badge, R.M., Lutz-Prigge, S., Farley, A.H., Moran, J.V. and Kazazian, H.H. Jr (2003) Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl Acad. Sci. USA, 100, 5280-5285
77. Goodier, J.L., Ostertag, E.M., Engleka, K.A., Seleme, M.C. and Kazazian, H.H. Jr (2004) A potential role for the nucleolus in L1 retrotransposition. Hum. Mol. Genet., 13, 1041-1048
78. Goodier, J.L., Zhang, L., Vetter, M.R. and Kazazian, H.H. Jr (2007) LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol. Cell. Biol., 27, 6469-6483
79. Goodier, J.L., Mandal, P.K., Zhang, L. and Kazazian, H.H. Jr (2010) Discrete subcellular partitioning of human retrotransposon RNAs despite a common mechanism of genome insertion. Hum. Mol. Genet., 19, 1712-1725
80. Lackey, L., Law, E.K., Brown, W.L. and Harris, R.S. (2013) Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. Cell Cycle, 12, 762-772
81. Goodier, J.L., Cheung, L.E. and Kazazian, H.H. Jr (2012) MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet., 8, e1002941
82. Eulalio, A., Behm-Ansmant, I. and Izaurralde, E. (2007) P bodies: At the crossroads of post-Transcriptional pathways. Nat. Rev. Mol. Cell Biol., 8, 9-22
83. Wang, T., Tian, C., Zhang, W., Luo, K., Sarkis, P.T., Yu, L., Liu, B., Yu, Y. and Yu, X.F. (2007) 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G. J. Virol., 81, 13112-13124
84. Guo, F., Cen, S., Niu, M., Saadatmand, J. and Kleiman, L. (2006) Inhibition of formula-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. J. Virol., 80, 11710-11722
85. Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J. and Yu, X.F. (2007) Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J. Virol., 81, 7238-7248
86. Wang, X., Ao, Z., Chen, L., Kobinger, G., Peng, J. and Yao, X. (2012) The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication. J. Virol., 86, 3777-3786
87. Doucet, A.J., Hulme, A.E., Sahinovic, E., Kulpa, D.A., Moldovan, J.B., Kopera, H.C., Athanikar, J.N., Hasnaoui, M., Bucheton, A., Moran, J.V. et al. (2010) Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet., 6, e1001150
88. Chiu, Y.L., Witkowska, H.E., Hall, S.C., Santiago, M., Soros, V.B., Esnault, C., Heidmann, T. and Greene, W.C. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl Acad. Sci. USA, 103, 15588-15593
89. Shindo, K., Takaori-Kondo, A., Kobayashi, M., Abudu, A., Fukunaga, K. and Uchiyama, T. (2003) The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J. Biol. Chem., 278, 44412-44416
90. Bulliard, Y., Turelli, P., Rohrig, U.F., Zoete, V., Mangeat, B., Michielin, O. and Trono, D. (2009) Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition. J. Virol., 83, 12611-12621
91. Prochnow, C., Bransteitter, R., Klein, M.G., Goodman, M.F. and Chen, X.S. (2007) The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature, 445, 447-451
92. Vasudevan, A.A., Smits, S.H., Hoppner, A., Haussinger, D., Koenig, B.W. and Münk, C. (2013) Structural features of antiviral DNA cytidine deaminases. Biol. Chem., 394, 1357-1370
93. Goodier, J.L., Cheung, L.E. and Kazazian, H.H. Jr (2013) Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition. Nucleic Acids Res., 41, 7401-7419
94. Strub, K. and Walter, P. (1990) Assembly of the Alu domain of the signal recognition particle (SRP): Dimerization of the two protein components is required for efficient binding to SRP RNA. Mol. Cell. Biol., 10, 777-784
95. Chiu, Y.L., Soros, V.B., Kreisberg, J.F., Stopak, K., Yonemoto, W. and Greene, W.C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+T cells. Nature, 435, 108-114
96. Wang, T., Zhang, W., Tian, C., Liu, B., Yu, Y., Ding, L., Spearman, P. and Yu, X.F. (2008) Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C. Virology, 377, 71-79
97. Hohjoh, H. and Singer, M.F. (1997) Sequence-specific singlestrand RNA binding protein encoded by the human LINE-1 retrotransposon. EMBO J., 16, 6034-6043
98. Kolosha, V.O. and Martin, S.L. (1997) In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retrotransposition. Proc. Natl Acad. Sci. USA, 94, 10155-10160
99. Lovsin, N. and Peterlin, B.M. (2009) APOBEC3 proteins inhibit LINE-1 retrotransposition in the absence of ORF1p binding. Ann. N Y Acad. Sci., 1178, 268-275
100. Kozak, S.L., Marin, M., Rose, K.M., Bystrom, C. and Kabat, D. (2006) The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem., 281, 29105-29119
101. Wichroski, M.J., Robb, G.B. and Rana, T.M. (2006) Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog., 2, e41
102. Gallois-Montbrun, S., Kramer, B., Swanson, C.M., Byers, H., Lynham, S., Ward, M. and Malim, M.H. (2007) Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol., 81, 2165-2178
103. Bishop, K.N., Holmes, R.K. and Malim, M.H. (2006) Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol., 80, 8450-8458
104. Carmi, S., Church, G.M. and Levanon, E.Y. (2011) Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution. Nat. Commun., 2, 519
105. Khan, H., Smit, A. and Boissinot, S. (2006) Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates. Genome Res., 16, 78-87